Stephens initiated coverage of Immunome (IMNM) with an Overweight rating and $30 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on IMNM: Immunome Advances with Strategic Asset Acquisition and Agreement Immunome presents preclinical data for IM-1021, ADC payload HC74 Immunome files to sell 230K shares of common stock for holders Immunome participates in a conference call with JPMorgan
